Strategic collaboration extends TOOsonix's reach into Poland, addressing skin diseases for a population of over 37 million.

COPENHAGEN, Denmark, March 27, 2025 /PRNewswire/ -- TOOsonix, a manufacturer of advanced dermatological therapy devices, has announced a strategic partnership with Consultronix, a prominent distributor of cutting-edge medical devices in Poland. The collaboration will introduce TOOsonix's state-of-the-art focused ultrasound skin therapy to the Polish market, providing healthcare professionals with a new innovative solution for treating skin diseases.

TOOsonix's MDR CE-marked dermatological therapy addresses a wide range of age-related skin diseases, including very common basal cell carcinoma, actinic keratosis, and seborrheic keratosis. Treatments are fast, non-invasive, without need for anesthesia or post treatment, and have higher efficacy and better aesthetic outcome than traditional procedures.

With approximately 20% of Poland's population aged 65 and over, this partnership aims to improve care for this growing demographic affected by skin diseases. Leveraging Consultronix's expertise and extensive network in hospitals and private clinics, the collaboration seeks to make these advanced therapies accessible to patients across the country.

"We are thrilled to partner with Consultronix to expand our presence in Central Europe," said Torsten Bove and Tomasz Zawada, founders of TOOsonix. "Consultronix's deep understanding of the Polish market and commitment to quality make them an ideal partner. Together, we aim to enhance patient outcomes by offering innovative dermatological solutions."

Consultronix has extensive experience in introducing advanced medical technologies to Poland. Their established relationships with dermatology clinics and hospitals will ensure a successful rollout of TOOsonix's products.

"We are proud to collaborate with TOOsonix," said Piotr Smolarski, CEO of Consultronix. "Their groundbreaking dermatological therapies align perfectly with our mission to equip Polish healthcare professionals with the best tools for addressing evolving patient needs."

This partnership marks another milestone in TOOsonix's international expansion strategy, reinforcing its commitment to making cutting-edge dermatological therapies available across Europe.

About TOOsonix:
TOOsonix pioneers high-intensity focused ultrasound technology for treating cancerous, pre-cancerous, and benign skin conditions. The company collaborates with healthcare professionals across Europe and the U.S. to deliver safe and effective solutions.
More at www.toosonix.com.

About Consultronix:
Consultronix is a leading distributor of medical devices in Poland with a strong focus on innovation and customer satisfaction. For over 38 years, it has been a trusted partner for healthcare professionals nationwide.
More at www.consultronix.pl.

Contact:
Torsten Bove
Managing Director
Ph: +45 2059 2999
Email: torsten.bove@toosonix.com

Logo -
Logo -
Photo -
Photo -

View original content:https://www.prnewswire.co.uk/news-releases/toosonix-partners-with-consultronix-to-introduce-its-innovative-dermatological-therapy-in-poland-302413165.html

Images

Tags

More Like This

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

Scantox Group acquires Gentronix, a world leader in genetic toxicology

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

DEKA Plays Its Poker Quad With Four New Laser Platforms at IMCAS Paris, the World Dermatology and Plastic and Aesthetic Surgery Congress

Sonata Software to Open Delivery Centre in Poland to Address the Growing Demands from its Global Clients

HistoSonics Awarded Key Position in UK’s Novel Innovation Program